✦ LIBER ✦

282 POSTER Preliminary results of a Phase I accelerated dose-escalation, pharmacokinetic and pharmacodynamic study of PF-03814735, an oral Aurora kinase A and B inhibitor, in patients with advanced solid tumors

✍ Scribed by P. Schöffski; H. Dumez; S.F. Jones; C. Fowst; P. Gerletti; H. Xu; J. Jakubczak; J. Infante; N. Mellaerts; H.A. Burris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I, open-label, multicentre, dose-e

✍ Patrick Schöffski; Suzanne F. Jones; Herlinde Dumez; Jeffrey R. Infante; Elke Va 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Phase I dose escalation study of MK-0457

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

218 POSTER A phase I dose-escalation stu

✍ E. Calvo; G. Edelman; J. Baselga; E. Kwak; C. Scheffold; L. Nguyen; G.I. Shapiro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

397 POSTER A phase I dose escalation and

✍ R.A. Fleming; K.D. Holen; T.L. Cyr; B.M. Johnson; J.L.S. Gauvin; J.J. Lager; B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase I safety, pharmacokinetic, and pha

✍ Markman, B.; Tabernero, J.; Krop, I.; Shapiro, G. I.; Siu, L.; Chen, L. C.; Mita 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 362 KB

97 POSTER A phase I dose-escalation stud

✍ K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB